SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (871)12/8/2003 1:25:15 PM
From: tuck  Read Replies (1) of 1005
 
>>BTW, you probably own some amev yourself. Given any thought to keeping lly?<<

None. My Mom owned AMEV. She sold at $17.75 on my recommendation. I gather Lilly is a class act relative to most pharmas -- somewhat less dire patent issues -- but I do not know enough about it to keep it. I think greater leverage will be found elsewhere, with risk/reward not too far away from that of Lilly. Not right away. I think the market still has some correcting to do, and am trying to hoard cash.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News